These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 31629111)
1. Increased levels of inflammatory biomarker CX3CL1 in patients with chronic obstructive pulmonary disease. Hao W; Li M; Zhang C; Zhang Y; Du W Cytokine; 2020 Feb; 126():154881. PubMed ID: 31629111 [TBL] [Abstract][Full Text] [Related]
2. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627 [TBL] [Abstract][Full Text] [Related]
3. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers. Hao W; Li M; Zhang Y; Zhang C; Wang P Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients. Hao W; Li M; Zhang C; Zhang Y; Wang P Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512 [No Abstract] [Full Text] [Related]
5. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638 [TBL] [Abstract][Full Text] [Related]
6. Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease. Bchir S; Nasr HB; Bouchet S; Benzarti M; Garrouch A; Tabka Z; Susin S; Chahed K; Bauvois B J Cell Mol Med; 2017 Jul; 21(7):1280-1291. PubMed ID: 28004483 [TBL] [Abstract][Full Text] [Related]
7. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148 [TBL] [Abstract][Full Text] [Related]
8. High Serum Fractalkine/CX3CL1 in Patients with Chronic Obstructive Pulmonary Disease: Relationship with Emphysema Severity and Frequent Exacerbation. Hao W; Li M; Zhang C; Zhang Y; Xue Y Lung; 2019 Feb; 197(1):29-35. PubMed ID: 30382361 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction. Lindenmaier TJ; Kirby M; Paulin G; Mielniczuk L; Cunningham IA; Mura M; Licskai C; Parraga G COPD; 2016; 13(2):224-34. PubMed ID: 26606693 [TBL] [Abstract][Full Text] [Related]
10. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease]. Kong YJ; Sun WX; Zhang YM; Shi YZ Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786 [TBL] [Abstract][Full Text] [Related]
11. Serum angiopoietin-like 4 is over-expressed in COPD patients: association with pulmonary function and inflammation. Wu YQ; Shen YC; Wang H; Zhang JL; Li DD; Zhang X; Wang T; Xu D; Ying BW; Wang LL; Wen FQ Eur Rev Med Pharmacol Sci; 2016; 20(1):44-53. PubMed ID: 26813452 [TBL] [Abstract][Full Text] [Related]
12. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity. Chaudhuri R; McSharry C; Brady J; Donnelly I; Grierson C; McGuinness S; Jolly L; Weir CJ; Messow CM; Spears M; Miele G; Nocka K; Crowther D; Thompson J; Brannigan M; Lafferty J; Sproule M; Macnee W; Connell M; Murchison JT; Shepherd MC; Feuerstein G; Miller DK; Thomson NC J Allergy Clin Immunol; 2012 Mar; 129(3):655-663.e8. PubMed ID: 22305682 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction. López-Sánchez M; Muñoz-Esquerre M; Huertas D; Montes A; Molina-Molina M; Manresa F; Dorca J; Santos S Clin Respir J; 2017 Nov; 11(6):859-866. PubMed ID: 26663885 [TBL] [Abstract][Full Text] [Related]
14. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H; Luo H; Chen P; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [TBL] [Abstract][Full Text] [Related]
15. Soluble receptor for advanced glycation end-products and progression of airway disease. Iwamoto H; Gao J; Pulkkinen V; Toljamo T; Nieminen P; Mazur W BMC Pulm Med; 2014 Apr; 14():68. PubMed ID: 24758342 [TBL] [Abstract][Full Text] [Related]
16. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease. Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735 [TBL] [Abstract][Full Text] [Related]
17. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses]. Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974 [TBL] [Abstract][Full Text] [Related]
18. [Quantitative analysis of emphysema and air trapping at inspiratory and expiratory phase multi-slice spiral CT scan in smokers: correlation with pulmonary function test]. Zhang D; Guan Y; Fan L; Xia Y; Liu SY Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1467-1473. PubMed ID: 29804412 [No Abstract] [Full Text] [Related]
19. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease]. Li L; Liu Y; Li J; Gao JM Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940 [No Abstract] [Full Text] [Related]
20. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD? Sarioglu N; Hismiogullari AA; Bilen C; Erel F Rev Port Pneumol (2006); 2016; 22(1):11-7. PubMed ID: 26534740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]